Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The new strategy coincides with the launch of Genomics Data Infrastructure Ireland, a separate project for Irish genomic and clinical data.
Among many objectives, the project will perform whole-genome sequencing of 10,000 individuals to build out its reference genome set.
The initiative will expand on the expertise gained through the use of genomic sequencing during the ongoing COVID-19 pandemic, applying it to other respiratory pathogens.
The grant was recently awarded through the EU's Cancer Mission, a funding program to reduce cancer cases throughout the EU by 2030.
The project, called PCR-4-All, officially commenced Dec. 1 and will run through November 2026.
The UK government said it will also invest £26 million to support cancer genomics research, and an additional £22 million to improve genomic data diversity.
Among the objectives of the CGI-Clinics effort is to have a CE-IVD marked analysis tool available by the end of 2027.
The researchers, based in the UK and Estonia, also recently released a tool to factor genetic ancestry into polygenic score calculations.
The Danish rare cell diagnostics company is also in the process of migrating its tests from array comparative hybridization to next-generation sequencing.
CEO and Cofounder İbrahim Çağrı Kurt discussed the new test during a presentation at Slush, an annual startup conference held in Helsinki this week.